Skip to content

Clinical trials

Phase 1 Head and Neck Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 1 Country / region: South Korea Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20181
20202
20211
20223
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status4
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wellmarker Bio2
AstraZeneca1
Bayer1
EMD Serono Research & Development Institute, Inc.1
EpiBiologics1
Genexine, Inc.1
ISU Abxis Co., Ltd.1
Mirati Therapeutics Inc.1
Novartis Pharmaceuticals1
Oscotec Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms14
Carcinoma, Non-Small-Cell Lung7
Colorectal Neoplasms7
Breast Neoplasms4
Lung Neoplasms4
Neoplasm Metastasis3
Neoplasms3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Carcinoma, Renal Cell2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.